ModelEdge
Jasper Therapeutics Inc.
JSPR
Filing type
8-K/A
Filing date
Sep 30, 2026
Updated
Oct 1, 2026 ยท 3:29 PM

Filing

8-K/AAmended material disclosure

Exhibits

EX-23.1CONSENT OF EISNERAMPER LLP, INDEPENDENT AUDITORS OF KIRA PHARMACEUTICALSEX-99.1Amended material disclosureEX-99.2Amended material disclosureEX-99.3Amended material disclosure